Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Phase 1 Study of Fianlimab (Anti-Lag-3) in Combination with Cemiplimab (Anti-Pd-1) in Patients with Advanced Melanoma: Poor-prognosis Subgroup Analysis

JOURNAL OF CLINICAL ONCOLOGY(2023)

Cited 0|Views44
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined